Both Sifrol and Cogentin are used to treat the symptoms of Parkinson's disease, but they belong to two different classes of medications that work by different mechanisms to address the dopamine deficiency in the brain associated with the disease. Additionally, Cogentin is also available in the form of injection ampoules, which expands its use in certain conditions.
Ingredients of Sifrol Tablets
Sifrol tablets contain the active ingredient pramipexole. Pramipexole is a dopamine agonist, meaning it mimics the effect of dopamine in the brain by binding to and activating dopamine receptors. It helps relieve symptoms of Parkinson's disease such as tremor, rigidity, slowness of movement, and difficulty with balance. Sifrol is available in the form of tablets for oral administration.
Ingredients of Cogentin Ampoules
Cogentin Ampoules contain the active ingredient benztropine mesylate. Benztropine is an anticholinergic drug that works by blocking the action of a chemical called acetylcholine in the brain. In Parkinson's disease, an imbalance occurs between dopamine and acetylcholine. Blocking acetylcholine can help relieve some symptoms, especially tremors and rigidity. Cogentin is available as tablets for swallowing and ampoules for intramuscular or intravenous injection.
About Sifrol Tablets
Drug Class: Dopamine Agonists
Drug Classification: Non-Ergot
Pharmaceutical Form: Tablets
Pharmacological Family: Central Nervous System Drugs, Drugs for the Treatment of Parkinson's Disease
Active Ingredient: Pramipexole
About Cogentin Ampoules
Drug Class: Anticholinergic
Drug Classification: Tertiary Amine
Pharmaceutical Form: Ampoules for Injection (also available as tablets)
Pharmacological Family: Central Nervous System Drugs, Drugs for the Treatment of Parkinson's Disease
Active Ingredient: Benztropine Mesylate